ProPhase Labs’ Resolution for 2025: Nail Down a ‘Liquidity Event’
The company has lost nearly $36 million since 2023, but its CEO is aggressively pursuing new revenue options
Keeps You Up-to-Date on Lab Business and Competitive Strategy, Market Trends and Opportunities, and M&A and Investment Activity in Today’s Diagnostic Lab Industry
The company has lost nearly $36 million since 2023, but its CEO is aggressively pursuing new revenue options
From - Laboratory Industry Report
LabCorp has received emergency approval from the U.S. Food and Drug Administration for a molecular-based rapid detection test for…
From - Laboratory Industry Report
The California-based molecular laboratory Veracyte has published a new study suggesting its Percepta bronchial genomic test can reduce the rate of…
From - Laboratory Industry Report
A new study in the New England Journal of Medicine has given credence to a molecular assay by California-based Genomic Health as a…
From - Laboratory Industry Report
While Theranos initially set out to change the laboratory sector with its Edison testing platform, to date it has mostly changed…